| 8th Feb 2023 7:00 am |
RNS |
Issue of Equity |
| 1st Feb 2023 7:00 am |
RNS |
Dr Jean-Michel Cosséry appointed as Chairman |
| 25th Jan 2023 7:00 am |
RNS |
Interim Results |
| 18th Jan 2023 7:00 am |
RNS |
Notice of Interim Results |
| 6th Dec 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 6th Dec 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 21st Nov 2022 3:18 pm |
RNS |
Result of Annual General Meeting |
| 7th Nov 2022 7:00 am |
RNS |
Licenses Vaccitech technology to advance Modi-2 |
| 31st Oct 2022 7:00 am |
RNS |
First patient dosed in expansion phase of ModiFY |
| 28th Oct 2022 3:00 pm |
RNS |
Notice of AGM |
| 28th Oct 2022 7:00 am |
RNS |
Results for the year ended 30 April 2022 |
| 26th Oct 2022 7:00 am |
RNS |
Directorate Changes |
| 25th Oct 2022 4:42 pm |
RNS |
Second Price Monitoring Extn |
| 25th Oct 2022 4:37 pm |
RNS |
Price Monitoring Extension |
| 25th Oct 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 25th Oct 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 25th Oct 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 25th Oct 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 25th Oct 2022 7:00 am |
RNS |
Signs Commercial License Agreement with Genmab |
| 13th Oct 2022 7:00 am |
RNS |
Change of Nominated Adviser |
| 28th Sep 2022 12:31 pm |
RNS |
Holding(s) in Company |
| 23rd Sep 2022 7:00 am |
RNS |
Preclinical data at the EuroMAbNet Annual Meeting |
| 23rd Sep 2022 7:00 am |
RNS |
Preclinical data at the EuroMAbNet Annual Meeting |
| 6th Sep 2022 12:54 pm |
RNS |
Change of Registered Office |
| 16th Aug 2022 2:00 pm |
RNS |
First patient dosed in Cohort 2 of the ModiFY |
| 23rd Jun 2022 7:00 am |
RNS |
Scancell to produce TCB antibodies |
| 15th Jun 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 15th Jun 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 15th Jun 2022 7:00 am |
RNS |
Phase 2 SCOPE trial of SCIB1 vaccine expanded |
| 13th Jun 2022 7:00 am |
RNS |
First patient dosed in Modi-1 Phase 1 trial |
| 12th Apr 2022 3:47 pm |
RNS |
Change of Registered Holder of Shares |
| 11th Apr 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 11th Apr 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 11th Apr 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 11th Apr 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 11th Apr 2022 7:00 am |
RNS |
Modi-1 Phase 1/2 trial open for recruitment |
| 29th Mar 2022 7:00 am |
RNS |
Update on COVIDITY clinical trial |
| 17th Mar 2022 7:00 am |
RNS |
Scancell progresses its new anti-glycan mAb |
| 3rd Mar 2022 9:55 am |
RNS |
Director Dealing |
| 31st Jan 2022 7:00 am |
RNS |
Update on COVIDITY Phase 1 clinical trial |
